Renaissance Technologies’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Buy |
|
|||||
|
2025
Q1 | $1.46M | Buy |
|
|||||
|
2024
Q4 | $2.11M | Sell |
|
|||||
|
2024
Q3 | $1.58M | Buy |
|
|||||
|
2024
Q2 | $1.01M | Sell |
|
|||||
|
2024
Q1 | $2.08M | Sell |
|
|||||
|
2023
Q4 | $1.83M | Buy |
|
|||||
|
2023
Q3 | $4.44M | Sell |
|
|||||
|
2023
Q2 | $10.1M | Sell |
|
|||||
|
2023
Q1 | $10.1M | Buy |
|
|||||
|
2022
Q4 | $17.7M | Sell |
|
|||||
|
2022
Q3 | $18.7M | Sell |
|
|||||
|
2022
Q2 | $18.6M | Sell |
|
|||||
|
2022
Q1 | $25.1M | Sell |
|
|||||
|
2021
Q4 | $24.4M | Sell |
|
|||||
|
2021
Q3 | $36.4M | Sell |
|
|||||
|
2021
Q2 | $42.7M | Sell |
|
|||||
|
2021
Q1 | $75.3M | Sell |
|
|||||
|
2020
Q4 | $21.1M | Sell |
|
|||||
|
2020
Q3 | $8.82M | Buy |
|
|||||
|
2020
Q2 | $5.31M | Buy |
|
|||||
|
2020
Q1 | $3.3M | Buy |
|
|||||
|
2019
Q4 | $5.26M | Buy |
|
|||||
|
2019
Q3 | $2.13M | Buy |
|
|||||
|
2019
Q2 | $1.53M | Buy |
|
|||||
|
2019
Q1 | $2.56M | Buy |
|
|||||
|
2018
Q4 | $707K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $784K | Sell |
|
|||||
|
2017
Q1 | $2.63M | Sell |
|
|||||
|
2016
Q4 | $4.74M | Buy |
|